Illinois CancerCare, P.C.
2 clinical trials · Sponsor
◉ Watch Illinois CancerCare, P.C.
| Record | Firm | Date |
|---|---|---|
| GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line (NCT01049776) | Illinois CancerCare, P.C. | 2010-01-01 |
| Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade (NCT00945477) | Illinois CancerCare, P.C. | 2009-07-01 |
Track Illinois CancerCare, P.C. automatically
Every clearance here is in the API, with alerts when new ones post.